[HTML][HTML] A cleavable peptide adapter augments the activity of targeted toxins in combination with the glycosidic endosomal escape enhancer SO1861
FJ Schulze, M Asadian-Birjand, M Pradela, N Niesler… - BMC …, 2024 - Springer
Background Treatment with tumor-targeted toxins attempts to overcome the disadvantages
of conventional cancer therapies by directing a drug's cytotoxic effect specifically towards …
of conventional cancer therapies by directing a drug's cytotoxic effect specifically towards …
A cleavable peptide adapter augments the activity of targeted toxins in combination with the glycosidic endosomal escape enhancer SO1861
FJ Schulze, M Asadian-Birjand… - BMC …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Treatment with tumor-targeted toxins attempts to overcome the disadvantages
of conventional cancer therapies by directing a drug's cytotoxic effect specifically towards …
of conventional cancer therapies by directing a drug's cytotoxic effect specifically towards …
[HTML][HTML] A cleavable peptide adapter augments the activity of targeted toxins in combination with the glycosidic endosomal escape enhancer SO1861
FJ Schulze, M Asadian-Birjand… - BMC …, 2024 - bmcbiotechnol.biomedcentral.com
Treatment with tumor-targeted toxins attempts to overcome the disadvantages of
conventional cancer therapies by directing a drug's cytotoxic effect specifically towards …
conventional cancer therapies by directing a drug's cytotoxic effect specifically towards …
[HTML][HTML] A cleavable peptide adapter augments the activity of targeted toxins in combination with the glycosidic endosomal escape enhancer SO1861
FJ Schulze, M Asadian-Birjand, M Pradela… - BMC …, 2024 - ncbi.nlm.nih.gov
Background Treatment with tumor-targeted toxins attempts to overcome the disadvantages
of conventional cancer therapies by directing a drug's cytotoxic effect specifically towards …
of conventional cancer therapies by directing a drug's cytotoxic effect specifically towards …
A cleavable peptide adapter augments the activity of targeted toxins in combination with the glycosidic endosomal escape enhancer SO1861.
FJ Schulze, M Asadian-Birjand, M Pradela… - BMC …, 2024 - europepmc.org
Background Treatment with tumor-targeted toxins attempts to overcome the disadvantages
of conventional cancer therapies by directing a drug's cytotoxic effect specifically towards …
of conventional cancer therapies by directing a drug's cytotoxic effect specifically towards …
A cleavable peptide adapter augments the activity of targeted toxins in combination with the glycosidic endosomal escape enhancer SO1861.
FJ Schulze, M Asadian-Birjand, M Pradela… - BMC …, 2024 - search.ebscohost.com
Background: Treatment with tumor-targeted toxins attempts to overcome the disadvantages
of conventional cancer therapies by directing a drug's cytotoxic effect specifically towards …
of conventional cancer therapies by directing a drug's cytotoxic effect specifically towards …
[PDF][PDF] A cleavable peptide adapter augments the activity of targeted toxins in combination with the glycosidic endosomal escape enhancer SO1861
FJ Schulze, M Asadian‑Birjand, M Pradela… - 2024 - bmcbiotechnol.biomedcentral.com
Background Treatment with tumor‑targeted toxins attempts to overcome the disadvantages
of conventional cancer therapies by directing a drug's cytotoxic effect specifically towards …
of conventional cancer therapies by directing a drug's cytotoxic effect specifically towards …